Condition
GAVE - Gastric Antral Vascular Ectasia
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown1
Withdrawn1
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06830317Not Yet RecruitingPrimary
Study on the Efficacy of Endoscopic Radiofrequency Treatment in Reducing the Need for Blood Transfusions in GAVE
NCT04760873Not ApplicableWithdrawnPrimary
Cryotherapy for GAVE
NCT05258604Not ApplicableUnknownPrimary
Endoscopic Band Ligation Vs APC in Management of GAVE
Showing all 3 trials